These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4063134)

  • 1. DNA index of ovarian carcinomas from 56 patients: in vivo in vitro studies.
    Erba E; Vaghi M; Pepe S; Amato G; Bistolfi M; Ubezio P; Mangioni C; Landoni F; Morasca L
    Br J Cancer; 1985 Oct; 52(4):565-73. PubMed ID: 4063134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric analysis of DNA content in human ovarian cancers.
    Erba E; Ubezio P; Pepe S; Vaghi M; Marsoni S; Torri W; Mangioni C; Landoni F; D'Incalci M
    Br J Cancer; 1989 Jul; 60(1):45-50. PubMed ID: 2803914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric analysis of DNA and cell proliferation in ovarian tumors.
    Christov K; Vassilev N
    Cancer; 1988 Jan; 61(1):121-5. PubMed ID: 3334938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of cellular DNA content on survival in ovarian carcinoma.
    Klemi PJ; Joensuu H; Mäenpää J; Kiilholma P
    Obstet Gynecol; 1989 Aug; 74(2):200-4. PubMed ID: 2748056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour ploidy, morphometry, histological grading and clinical features in ovarian carcinoma: mutual relations.
    Haapasalo H; Atkin NB; Collan Y; Pesonen E; Paljärvi L
    Anal Cell Pathol; 1991 Sep; 3(5):261-71. PubMed ID: 1931753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brenner tumours of the ovary: a study of the histology, immunohistochemistry and cellular DNA content in benign, borderline and malignant ovarian tumours.
    Trebeck CE; Friedlander ML; Russell P; Baird PJ
    Pathology; 1987 Jul; 19(3):241-6. PubMed ID: 3324024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival.
    Coulson PB; Thornthwaite JT; Woolley TW; Sugarbaker EV; Seckinger D
    Cancer Res; 1984 Sep; 44(9):4187-96. PubMed ID: 6744328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA flow cytometry, histological grade, stage, and age as prognostic factors in human epithelial ovarian carcinomas.
    Rutgers DH; Wils IS; Schaap AH; van Lindert AC
    Pathol Res Pract; 1987 Apr; 182(2):207-13. PubMed ID: 3601797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA flow cytometry of ovarian tumors with correlation to histopathology.
    Feichter GE; Kühn W; Czernobilsky B; Müller A; Heep J; Abel U; Haag D; Kaufmann M; Rummel HH; Kubli F
    Int J Gynecol Pathol; 1985; 4(4):336-45. PubMed ID: 3002995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of tamoxifen upon cell DNA analysis by flow cytometry in primary carcinoma of the breast.
    Baildam AD; Zaloudik J; Howell A; Barnes DM; Moore M; Sellwood RA
    Br J Cancer; 1987 May; 55(5):561-6. PubMed ID: 3606948
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometry of lung carcinoma: a comparison of DNA stemline and cell cycle distribution with histology.
    Ołszewski W; Darzynkiewicz Z; Claps ML; Melamed MR
    Anal Quant Cytol; 1982 Jun; 4(2):90-8. PubMed ID: 6287892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flow cytometric analysis of cellular DNA content as an adjunct to the diagnosis of ovarian tumours of borderline malignancy.
    Friedlander ML; Russell P; Taylor IW; Hedley DW; Tattersall MH
    Pathology; 1984 Jul; 16(3):301-6. PubMed ID: 6514398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual-parameter flow cytometric analysis coupling the measurements of forward-angle light scatter and DNA content of archival ovarian carcinomas of low malignant potential.
    Eriksen B; Miller DS; Murad TM; Lurain JR; Bauer KD
    Anal Quant Cytol Histol; 1991 Feb; 13(1):45-53. PubMed ID: 2025373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular DNA content--a stable feature in epithelial ovarian cancer.
    Friedlander ML; Taylor IW; Russell P; Tattersall MH
    Br J Cancer; 1984 Feb; 49(2):173-9. PubMed ID: 6696818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [DNA impulse cytophotometry measurements in head and neck tumors. Initial results of a correlation with clinical stage, therapeutic response and pattern of recurrence].
    Fietkau R; Iro H; Bilek P; Sauer R
    HNO; 1989 Feb; 37(2):62-6. PubMed ID: 2703374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytofluorometric DNA analyses of metastases of human malignant melanomas.
    Hansson J; Tribukait B; Lewensohn R; Ringborg U
    Anal Quant Cytol; 1982 Jun; 4(2):99-104. PubMed ID: 7114625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flow cytometry as a tool for the prognostic assessment of patients with lung and ovarian carcinomas.
    Volm M; Drings P; Kleine W; Mattern J
    Strahlenther Onkol; 1987 Dec; 163(12):791-4. PubMed ID: 2827331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical DNA flow cytometry.
    Tribukait B
    Med Oncol Tumor Pharmacother; 1984; 1(4):211-8. PubMed ID: 6544901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic relevance of ploidy, proliferation, and resistance-predictive tests in ovarian carcinoma.
    Volm M; Brüggemann A; Günther M; Kleine W; Pfleiderer A; Vogt-Schaden M
    Cancer Res; 1985 Oct; 45(10):5180-5. PubMed ID: 4027994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The flow-cytometric analysis of DNA content and S-phase fraction (SPF) of human breast cancer.
    Eskelinen M; Nordling S; Puittinen J; Pesonen E; Collan Y
    Pathol Res Pract; 1989 Nov; 185(5):694-7. PubMed ID: 2626377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.